The Doctor Is IN! | September 2025

Jonathan Poyer

Oct 61 min read

Riffin' on Real Estate | September 2025

Jonathan Poyer

Oct 61 min read

8 Robotics & Automation Companies to Keep Your Eye On

Robotics & Automation

Jonathan Poyer

Aug 114 min read

ADA Conference Highlights GLP-1 Data and Continued Weight Loss Impacts

Biotech & Healthcare

Jonathan Poyer

Jun 231 min read

June 2025 Riffin' on Real Estate

Videos

Jonathan Poyer

Jun 111 min read

Looking At Palantir Technologies (PLTR) and its +74.24% Stock Rise into June

Macro Views

Jonathan Poyer

Jun 62 min read

Sanofi with a $9.1B Acquisition of Blueprint & Cancer Conference Shows Successes for Diagnostics, Therapy, and Treatments

Biotech & Healthcare

Jonathan Poyer

Jun 42 min read

The Doctor is IN | May 2025

Dr. is IN Monthly Call Recordings

Jonathan Poyer

May 161 min read

Where Are the Biotech IPOs and Deals?

Biotech & Healthcare

Jonathan Poyer

May 161 min read

Commerical Aerospace Ideas and Why It is an Interesting Mid- and Long-Term Investing Opportunity

Macro Views

Jonathan Poyer

May 124 min read

Novartis to Acquire Regulus Therapeutics for $1.7B

Biotech & Healthcare

Jonathan Poyer

Apr 301 min read

Following the Trend Following Trend...

Macro Views

Jonathan Poyer

Apr 252 min read

The Doctor is IN | April 2025

Jonathan Poyer

Apr 221 min read

Merck's Announcement of Successful Phase 3 Trial of Subcutaneous Keytruda Progresses Towards FDA Submission

Biotech & Healthcare

Jonathan Poyer

Mar 312 min read

AbbVie and the Influence of AI on Research

Biotech & Healthcare

Jonathan Poyer

Mar 241 min read

March Shows Some Life for Biotech M&A With Over $1.7B in Deals.

Biotech & Healthcare

Jonathan Poyer

Mar 211 min read

The Doctor is IN | March 2025

Dr. is IN Monthly Call Recordings

Jonathan Poyer

Mar 211 min read

Patient Death Associated with Sarepta Drug - Stock Plummets

Biotech & Healthcare

Jonathan Poyer

Mar 211 min read

March 2025 Riffin' on Real Estate

Riffin' on Real Estate Recordings

Jonathan Poyer

Mar 131 min read

Medicare Advantage Rates Set to Increase. CVS Among Others Benefitting

Biotech & Healthcare

Jonathan Poyer

Mar 62 min read